{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:20:40Z","timestamp":1788790840771,"version":"build-2803163510"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.pnpbp.2020.109941","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T19:06:32Z","timestamp":1585681592000},"page":"109941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management"],"prefix":"10.1016","volume":"101","author":[{"given":"Alexandre","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Labad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary V.","family":"Seeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pnpbp.2020.109941_bb0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0033-3182(10)70718-0","article-title":"Management of psychosis associated with a prolactinoma: case report and review of the literature","volume":"51","author":"Ali","year":"2010","journal-title":"Psychosomatics."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0010","doi-asserted-by":"crossref","unstructured":"Alosaimi, F.D., Fallata, E.O., Abalhassan, M., Alhabbad,A., Alzain, N., Alhaddad, B., et al., 2018. Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications. Int. J. Psychiatry. Clin. Practice. 22 (4), 274\u201381. doi: https:\/\/doi.org\/10.1080\/13651501.2018.1425459.","DOI":"10.1080\/13651501.2018.1425459"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109941_bb0015","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/js.2017-00102","article-title":"Treatments to prevent bone loss in functional hypothalamic amenorrhea: a systematic review and meta-analysis","volume":"1","author":"Altayar","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0020","doi-asserted-by":"crossref","unstructured":"Ashraf, I., Rehman, I., Irshad, K., Shafi, R., 2019. Effect of kisspeptin on serum prolactin and gonadotropins levels in Balb-c mice with induced chronic stress. J. Coll. Physicians. Surg. Pak. 29(1), 41-44. Doi: 10.29271\/jcpsp.2019.01.41.","DOI":"10.29271\/jcpsp.2019.01.41"},{"issue":"8","key":"10.1016\/j.pnpbp.2020.109941_bb0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1212\/WNL.0000000000002252","article-title":"Cognitive functioning of patients with a PRL-secreting pituitary adenoma: a preliminary report","volume":"86","author":"Bala","year":"2016","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41380-018-0044-2","article-title":"Pharmacological treatment of adult bipolar disorder","volume":"24","author":"Baldessarini","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109941_bb0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1043-2760(02)00603-3","article-title":"Prolactin as an autocrine\/paracrine growth factor in human cancer","volume":"13","author":"Ben-Jonathan","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109941_bb0040","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/FTD.0000000000000041","article-title":"Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring","volume":"36","author":"Best-Shaw","year":"2014","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.psychres.2016.01.031","article-title":"Adjunctive metformin for antipsychotic-induced hyperprolactinemia: a systematic review","volume":"237","author":"Bo","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fimmu.2018.00073","article-title":"Prolactin and autoimmunity","volume":"9","author":"Borba","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1592\/phco.29.1.64","article-title":"Antipsychotic-induced hyperprolactinemia","volume":"29","author":"Bostwick","year":"2009","journal-title":"Pharmacother."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2020.109941_bb0060","first-page":"S261","article-title":"Effects of hormones on cognition in schizophrenic male patients--preliminary results","volume":"27","author":"Bratek","year":"2015","journal-title":"Psychiatr. Danub."},{"issue":"2 Suppl","key":"10.1016\/j.pnpbp.2020.109941_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0269881107088435","article-title":"A review of the association between antipsychotic use and hyperprolactinaemia","volume":"22","author":"Bushe","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0070","doi-asserted-by":"crossref","unstructured":"Campisi, J., Kapahi, P., Lithgrow, G.J., Melov, S., Newman, J.C., Verdin, E., 2019. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 571(7764), 183-192. Doi:10\/1038\/s41586-019-1365-2.","DOI":"10.1038\/s41586-019-1365-2"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109941_bb0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/acps.12794","article-title":"Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone and quetiapine","volume":"136","author":"Castberg","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109941_bb0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.9758\/cpn.2016.14.3.238","article-title":"Effects of antipsychotics on bone mineral density in patients with schizophrenia: gender differences","volume":"14","author":"Chen","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2020.109941_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1385\/ENDO:23:2-3:215","article-title":"Effects of raloxifene, one of the selective estrogen receptor modulators, on pituitary-ovary axis and prolactin in postmenopausal women","volume":"23","author":"Cheng","year":"2004","journal-title":"Endocrine."},{"issue":"8","key":"10.1016\/j.pnpbp.2020.109941_bb0090","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2826.2007.01567.x","article-title":"Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat","volume":"19","author":"Christian","year":"2007","journal-title":"J. Neuroendocrinol."},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2020.109941_bb0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0269881107087373","article-title":"Current guidelines and their recommendations for prolactin monitoring in psychosis","volume":"22","author":"Citrome","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109941_bb0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S2215-0366(15)00003-6","article-title":"New perspectives on schizophrenia in later life: implications for treatment, policy, and research","volume":"2","author":"Cohen","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109941_bb0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psc.2017.10.004","article-title":"Advances in the conceptualization and study of schizophrenia in later life","volume":"41","author":"Cohen","year":"2018","journal-title":"Psychiatr. Clin. N. America."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0115","series-title":"Advanced Age Geriatric Care","first-page":"145","article-title":"2019. Mental illness in the oldest-old","author":"Cullen","year":"2019"},{"key":"10.1016\/j.pnpbp.2020.109941_bb0120","doi-asserted-by":"crossref","unstructured":"Dall, G.V., Britt, K.L., 2017. Estrogen effects on the mammary gland in early and later life and breast cancer risk. Front. Oncol. 7:article 110. doi: https:\/\/doi.org\/10.3389\/fonc.2017.00110.","DOI":"10.3389\/fonc.2017.00110"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109941_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2042098618756261","article-title":"Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine","volume":"9","author":"De Berardis","year":"2018","journal-title":"Therap. Adv. Drug Safety."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109941_bb0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/acps.12459","article-title":"Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review","volume":"133","author":"De Hert","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-15-0282","article-title":"Breast cancer risk in hyperprolactinemia: a population-based cohort study and meta-analysis of the literature","volume":"173","author":"Dekkers","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109941_bb0140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1590\/2359-3997000000230","article-title":"Interactions between prolactin and kisspeptin to control reproduction","volume":"60","author":"Donato","year":"2016","journal-title":"Arch. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109941_bb0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00228-018-2603-5","volume":"75","author":"Fialov\u00e1","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.pnpbp.2020.109941_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0269216307087148","article-title":"Prolactin and dopamine: what is the connection? A review article","volume":"22","author":"Fitzgerald","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109941_bb0155","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.pnpbp.2020.109941_bb0160","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1111\/jcmm.13963","article-title":"Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts","volume":"22","author":"Gao","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.pnpbp.2020.109941_bb0165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/14656566.2018.1465563","article-title":"Pharmacotherapy for schizophrenia in postmenopausal women","volume":"19","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109941_bb0170","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/JCP.0000000000000571","article-title":"Antipsychotic response worsens with postmenopausal duration in women with schizophrenia","volume":"36","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109941_bb0175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/YIC.0000000000000227","article-title":"A systematic review of the operational definitions for antipsychotic response in delusional disorder","volume":"33","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2018","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0180","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Rodr\u00edguez, A., Esteve, M., \u00c1lvarez, A., Gu\u00e0rdia, A., Monreal, J.A., Palao, D., et al., 2019. What we know and still need to know about gender aspects of delusional disorder: a narrative review of recent work. J. Psychiatry. Brain. Sci. 4:e190009. Doi:10.20900\/jpbs.20190009.","DOI":"10.20900\/jpbs.20190009"},{"key":"10.1016\/j.pnpbp.2020.109941_bb0185","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14656566.3.10.1381","article-title":"Antipsychotics: impact on prolactin levels","volume":"3","author":"Goodnick","year":"2002","journal-title":"Expert. Opin. Pharmacother."},{"issue":"9","key":"10.1016\/j.pnpbp.2020.109941_bb0190","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jamapsychiatry.2015.0891","article-title":"Evaluation of antipsychotic dose reduction in late-life schizophrenia prospective dopamine D2\/3 receptor occupancy study","volume":"72","author":"Graff-Guerrero","year":"2015","journal-title":"JAMA. Psychiatry."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0195","doi-asserted-by":"crossref","first-page":"T101","DOI":"10.1530\/JOE-15-0213","article-title":"The hypothalamo-prolactin axis","volume":"226","author":"Grattan","year":"2015","journal-title":"J. Endocrinol."},{"issue":"22","key":"10.1016\/j.pnpbp.2020.109941_bb0200","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s00213-017-4730-6","article-title":"Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research","volume":"234","author":"Grigg","year":"2017","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0205","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/endo-108-2-440","article-title":"Role of estrogen in the dopaminergic control of prolactin secretion","volume":"108","author":"Gudelsky","year":"1981","journal-title":"Endocrinology."},{"issue":"20","key":"10.1016\/j.pnpbp.2020.109941_bb0210","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2020.109941_bb0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0306-4530(02)00112-9","article-title":"Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109941_bb0220","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ecl.2015.05.010","article-title":"Endocrinology of the menopause","volume":"44","author":"Hall","year":"2015","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"18","key":"10.1016\/j.pnpbp.2020.109941_bb0225","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/eurheartj\/ehs233","article-title":"Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality","volume":"35","author":"Haring","year":"2014","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109941_bb0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1037\/a0025540","article-title":"Hormones and cognitive functioning during late pregnancy and postpartum: a longitudinal study","volume":"126","author":"Henry","year":"2011","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0235","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4236\/oju.2012.223034","article-title":"The role of prolactin in the evolution of prostate cancer","volume":"2","author":"Hernandez","year":"2012","journal-title":"Open. J. Urology."},{"issue":"12","key":"10.1016\/j.pnpbp.2020.109941_bb0240","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1158\/1055-9965.EPI-14-0982","article-title":"Alcohol consumption in relation to plasma sex hormones, prolactin, and sex hormone-binding globulin in premenopausal women","volume":"23","author":"Hirko","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0245","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/appi.ajp.157.2.172","article-title":"The international late-onset schizophrenia group. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus","volume":"157","author":"Howard","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1185\/030079903125002865","article-title":"Hyperprolactinaemia and antipsychotic therapy in schizophrenia","volume":"20","author":"Hummer","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0255","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/00048674.2011.589044","article-title":"Antipsychotic-induced hyperprolactinaemia","volume":"45","author":"Inder","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0260","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2016.10.029","article-title":"Prolactin gene polymorphism (\u22121149 G\/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics","volume":"182","author":"Ivanova","year":"2017","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0265","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12026-016-8891-x","article-title":"Prolactin has a pathogenic role in systemic lupus erythematosus","volume":"65","author":"Jara","year":"2017","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109941_bb0270","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1017\/S1041610217001934","article-title":"Antipsychotic polypharmacy in older Australians","volume":"30","author":"Kalisch Ellett","year":"2018","journal-title":"Int. Psychogeriatr."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2020.109941_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mce.2005.04.008","article-title":"Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release","volume":"239","author":"Kansra","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0280","doi-asserted-by":"crossref","unstructured":"Karunakaran, S., Page, R.C., Wass, J.A., 2001. The effect of the menopause on prolactin levels in patients with hyperprolactinaemia. Clin. Endocrinol. (Oxf). 54(3), 295-300. doi: https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01190.x.","DOI":"10.1046\/j.1365-2265.2001.01190.x"},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109941_bb0285","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.tjog.2017.10.002","article-title":"Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia","volume":"56","author":"Kasum","year":"2017","journal-title":"Taiwan. J. Obstet. Gynecol."},{"issue":"24","key":"10.1016\/j.pnpbp.2020.109941_bb0290","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1200\/JCO.2009.26.4770","article-title":"Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use","volume":"28","author":"Kerlikowske","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2020.109941_bb0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0306-4530(02)00127-0","article-title":"Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone","volume":"28","author":"Kinon","year":"2003","journal-title":"Psychoneuroendocrinology."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109941_bb0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3371\/CSRP.KISE.020113","article-title":"Bone loss associated with hyperprolactinemia in patients with schizophrenia","volume":"7","author":"Kinon","year":"2013","journal-title":"Clin. Schizophr. Relat. Psychoses."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109941_bb0305","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1176\/appi.ajp.162.5.1010","article-title":"Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels","volume":"162","author":"Knegtering","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109941_bb0310","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejim.2016.01.015","article-title":"The effect of metformin on prolactin levels in patients with drug-induced hyperprolactinemia","volume":"30","author":"Krysiak","year":"2016","journal-title":"Eur. J. Intern. Med."},{"issue":"10","key":"10.1016\/j.pnpbp.2020.109941_bb0315","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.euroneuro.2016.08.006","article-title":"Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial","volume":"26","author":"Labad","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109941_bb0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.9758\/cpn.2019.17.3.333","article-title":"Serum prolactin and bone mineral density in schizophrenia: a systematic review","volume":"17","author":"Lally","year":"2019","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109941_bb0325","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/eje.0.1470461","article-title":"Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women","volume":"147","author":"Lasco","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0330","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.psyneuen.2011.04.007","article-title":"Prolactin in response to acute psychosocial stress in healthy men and women","volume":"36","author":"Lennartsson","year":"2011","journal-title":"Psychoneuroendocrinol."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109941_bb0335","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00406-004-0505-2","article-title":"Possible individual and gender differences in the small increases in plasma prolactin levels seen during clozapine treatment","volume":"254","author":"de Leon","year":"2004","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"9896","key":"10.1016\/j.pnpbp.2020.109941_bb0340","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0345","article-title":"Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2020.109941_bb0350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/CIA.S100274","article-title":"Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia","volume":"11","author":"Liang","year":"2016","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109941_bb0355","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12020-019-01896-y","article-title":"Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets","volume":"64","author":"Liu","year":"2019","journal-title":"Endocrine."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109941_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr1525","article-title":"Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies","volume":"8","author":"Ma","year":"2006","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109941_bb0365","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hup.1116","article-title":"Hyperprolactinemia associated with psychotropics--a review","volume":"25","author":"Madhusoodanan","year":"2010","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0370","first-page":"851","article-title":"Management of psychotropic-induced hyperprolactinemia","volume":"11","author":"Marken","year":"1991","journal-title":"Clin. Pharm."},{"issue":"9","key":"10.1016\/j.pnpbp.2020.109941_bb0375","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1185\/030079905X61839","article-title":"Safety assessment of raloxifene over eight years in a clinical trial setting","volume":"21","author":"Martino","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0380","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0385","doi-asserted-by":"crossref","unstructured":"Migliardi, G., Spina, E., D'Arrigo, C., Gagliano, A., German\u00f2, E., Siracusano, R., et al., 2009. Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents. Prog. Neuropsychopharmacol. Biol. Psychiatry. 13;33(8):1496-1501.","DOI":"10.1016\/j.pnpbp.2009.08.009"},{"issue":"8","key":"10.1016\/j.pnpbp.2020.109941_bb0390","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4065\/80.8.1050","volume":"80","author":"Molitch","year":"2005","journal-title":"Medication-induced hyperprolactinemia. Mayo. Clin. Proc."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0395","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11102-008-0106-6","article-title":"Drugs and prolactin","volume":"11","author":"Molitch","year":"2008","journal-title":"Pituitary."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089428","article-title":"Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis","volume":"9","author":"Montalvo","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0405","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/YIC.0000000000000199","article-title":"Improvement in cognitive abilities following cabergoline treatment in patients with a prolactin-secreting pituitary adenoma","volume":"33","author":"Montalvo","year":"2018","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109941_bb0410","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/0004867417744254","article-title":"Sex differences in the relationship between prolactin levels and impaired processing speed in early psychosis","volume":"52","author":"Montalvo","year":"2018","journal-title":"Aust. N. Z. J. Psychiatry."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109941_bb0415","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.rpsm.2015.11.003","article-title":"Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia","volume":"9","author":"Montejo","year":"2016","journal-title":"Rev. Psiquiatr. Salud. Ment."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yfrne.2017.02.003","article-title":"Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics","volume":"45","author":"Montejo","year":"2017","journal-title":"Front. Neuroendocrinol."},{"issue":"11","key":"10.1016\/j.pnpbp.2020.109941_bb0425","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4088\/JCP.v65n1108","article-title":"Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment","volume":"65","author":"Montgomery","year":"2004","journal-title":"J. Clin. Psychiatry."},{"issue":"9","key":"10.1016\/j.pnpbp.2020.109941_bb0430","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.psyneuen.2013.02.007","article-title":"Serum testosterone levels are related to cognitive function in men with schizophrenia","volume":"38","author":"Moore","year":"2013","journal-title":"Psychoneuroendocrinology."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109941_bb0435","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/JCP.0000000000000595","article-title":"A systematic review on the pharmacological treatment of delusional disorder","volume":"36","author":"Mu\u00f1oz-Negro","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"Suppl. 8","key":"10.1016\/j.pnpbp.2020.109941_bb0440","first-page":"13","article-title":"Use of atypical antipsychotics in refractory depression and anxiety","volume":"66","author":"Nemeroff","year":"2005","journal-title":"J. Clin. Psychiatry."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109941_bb0445","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/asj.12090","article-title":"Plasma cortisol and prolactin secretion rhythms in cattle under varying external environments and management techniques","volume":"85","author":"Ogino","year":"2014","journal-title":"Anim. Sci. J."},{"issue":"12","key":"10.1016\/j.pnpbp.2020.109941_bb0450","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jama.2017.12067","article-title":"Delirium in older persons: advances in diagnosis and treatment","volume":"318","author":"Oh","year":"2017","journal-title":"JAMA."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2020.109941_bb0455","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12881-019-0773-3","article-title":"A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia","volume":"20","author":"Osmanova","year":"2019","journal-title":"BMC. Med. Genet."},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2020.109941_bb0460","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0269881107087346","article-title":"Antipsychotics and hyperprolactinaemia: clinical recommendations","volume":"22","author":"Peveler","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109941_bb0465","first-page":"226","article-title":"Early hyperprolactinaemia in acute psychiatric inpatients: a cross-sectional study","volume":"21","author":"Pigato","year":"2015","journal-title":"J. Psychopathology."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109941_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/ADR-170042","article-title":"Increased all-cause mortality by antipsychotic drugs: updated review and meta-analysis in dementia and general mental health care","volume":"2","author":"Ralph","year":"2018","journal-title":"J. Alzheimers. Dis. Rep."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0475","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/gps.4758","article-title":"Therapeutic D2\/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP)","volume":"33","author":"Reeves","year":"2018","journal-title":"Int J Geriatr Psychiatry."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0480","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/CIRCGENETICS.109.853572","article-title":"Prolactin levels and the risk of future coronary artery disease in apparently healthy men and women","volume":"2","author":"Reuwer","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0485","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/JOE-10-0076","article-title":"The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis? J","volume":"208","author":"Reuwer","year":"2011","journal-title":"Endocrinol."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0490","doi-asserted-by":"crossref","unstructured":"Rosenbloom, A.L., 2010. Hyperprolactinemia with antipsychotic drugs in children and adolescents. Int. J. Pediatr. Endocrinol. 2010. Pii: 159402. doi: https:\/\/doi.org\/10.1155\/2010\/159402.","DOI":"10.1186\/1687-9856-2010-159402"},{"key":"10.1016\/j.pnpbp.2020.109941_bb0495","doi-asserted-by":"crossref","unstructured":"Santharam, S., Tampourlou, M., Arlt, W., Ayuk, J., Gittoes, N., Toogood, A., et al., 2017. Prolactinomas diagnosed in the postmenopausal period: clinical phenotype and outcomes. Clin. Endocrinol. (Oxf). 87(5), 508-514. doi: https:\/\/doi.org\/10.1111\/cen.13399.","DOI":"10.1111\/cen.13399"},{"key":"10.1016\/j.pnpbp.2020.109941_bb0500","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2217\/pgs-2018-0053","article-title":"Prolactin levels: sex differences in the effects of risperidone, 9-hydroxyrisperidone levels, CYP2D6 and ABCB1 variants","volume":"19","author":"Schoretsanitis","year":"2018","journal-title":"Pharmacogenomics."},{"issue":"10","key":"10.1016\/j.pnpbp.2020.109941_bb0505","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3109\/09513590.2015.1060957","article-title":"Transient psychosis in women on clomiphene, bromocriptine, domperidone and related endocrine drugs","volume":"31","author":"Seeman","year":"2015","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109941_bb0510","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/YCO.0000000000000410","article-title":"Use of psychotropic medication in women with psychotic disorders at menopause and beyond","volume":"31","author":"Seeman","year":"2018","journal-title":"Curr. Opin. Psychiatry."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0515","first-page":"53","article-title":"Aripiprazole-induced asymptomatic hypertension: a case report. Psychopharmacol","volume":"47","author":"Seven","year":"2017","journal-title":"Bull."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109941_bb0520","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0447.2007.01130.x","article-title":"Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder","volume":"117","author":"Shelton","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109941_bb0525","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12020-014-0259-1","article-title":"Women with prolactinomas presented at the postmenopausal period","volume":"47","author":"Shimon","year":"2014","journal-title":"Endocrine."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0530","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11154-019-09503-1","article-title":"Prolactin and human weight disturbances: a puzzling and neglected association","volume":"20","author":"Sobrinho","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0535","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psyneuen.2018.04.012","article-title":"Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis","volume":"93","author":"Soria","year":"2018","journal-title":"Psychoneuroendocrinology."},{"issue":"12","key":"10.1016\/j.pnpbp.2020.109941_bb0540","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2165\/11595830-000000000-00000","article-title":"Management of schizophrenia in late life with antipsychotic medications. A qualitative review","volume":"28","author":"Suzuki","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.pnpbp.2020.109941_bb0545","doi-asserted-by":"crossref","unstructured":"Teoh, S.K., Lex, B.W., Mendelson, J.H, Mello, N.K., Cochin, J., 1992. Hyperprolactinemia and macrocytosis in women with alcohol and polysubstance dependence. J. Stud. Alcohol 53(2), 176\u2013182.","DOI":"10.15288\/jsa.1992.53.176"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.115.002640","article-title":"Association between prolactin and incidence of cardiovascular risk factors in the Framingham heart study","volume":"5","author":"Therkelsen","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"10.1016\/j.pnpbp.2020.109941_bb0555","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/annonc\/mdu150","article-title":"Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort","volume":"25","author":"Tikk","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0560","first-page":"25","volume":"7","author":"Torner","year":"2016","journal-title":"Actions of prolactin in the brain: From physiological adaptations to stress and neurogenesis to psychopathology. Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0565","first-page":"929","article-title":"Pharmacological causes of hyperprolactinemia","volume":"3","author":"Torre","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109941_bb0570","first-page":"315","article-title":"Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1-12.5 years. Schizophr","volume":"45","author":"Vermeulen","year":"2019","journal-title":"Bull."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0575","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/NDT.S169369","article-title":"Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy","volume":"15","author":"Ward","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109941_bb0580","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mp.2015.11","article-title":"Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia","volume":"20","author":"Weickert","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109941_bb0585","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1016\/j.clbc.2018.10.012","article-title":"Meta-analysis of the correlation between schizophrenia and breast cancer","volume":"19","author":"Xiping","year":"2019","journal-title":"Clin. Breast. Cancer."},{"key":"10.1016\/j.pnpbp.2020.109941_bb0590","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3389\/fneur.2017.00742","article-title":"Cognitive function and serum hormone levels are associated with gray matter volume decline in female patients with prolactinomas","volume":"8","author":"Yao","year":"2018","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109941_bb0595","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/eje.0.1490187","article-title":"Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women","volume":"149","author":"Yavuz","year":"2003","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109941_bb0600","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0269881117699630","article-title":"Adjunctive metformin for antipsychotic-related hyperprolactinemia: a meta-analysis of randomized controlled trials","volume":"31","author":"Zheng","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109941_bb0605","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/JCP.0b013e3181e7810a","article-title":"Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis","volume":"30","author":"Zhornitsky","year":"2010","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584620302578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584620302578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:53:55Z","timestamp":1759521235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584620302578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":120,"alternative-id":["S0278584620302578"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109941","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109941"}}